Global Hematology Market to have a decent growth rate of 3-5% in the next 5 years

Global hematology market is driven by factors such as coagulation disorders, blood donations, POC diagnostics, advanced analyzers & reagents, flow cytometry, and post-COVID recovery.
BRUSSELS - June 14, 2023 - PRLog -- Hematology ( is a branch of medicine related to the study of blood and blood-forming organs. It encompasses a broad range of both non-cancerous and cancerous diseases and conditions affecting red and white blood cells, platelets, and the coagulation system in individuals of all ages. The specialists in hematology research, diagnose and treat a variety of conditions such as anemia, bleeding disorders such as hemophilia, blood clots, sickle cell disease, and blood cancers such as leukemia, lymphoma, and myeloma.

The Covid-19 pandemic had a positive impact on the hematology market as there was increasing focus on hematology parameters for the assessment of Covid-19 Worldwide. Covid-19 boosted the demand for hematology analyzers.

Technological Advancements in Hematology Analyzers Drives the Hematology Market

The hematology market has been marked by continuous technological advancements, which in turn is driving market growth. For instance,
  • In May 2023, Siemens Healthineers launched next-gen hematology analyzers for high-volume hematology testing, the Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer.
AI-Powered Automatic Hematology Analyzers Poised to Advance Diagnostic Capabilities of Laboratories

For analyzing hematological diseases, most of the available hematology analyzers offer only basic information. As the volume of information generated by hematology analyzers grows, clinicians and doctors are often overwhelmed with data and they face problems in analyzing critical information.

For instance, DH-615 hematology analyzer from Dymind Biotechnology, which is based on fluorescent nucleic acid staining technology and the company's proprietary AI Cube technology combines 6-DIFF with RET, significantly improves the detection of abnormal cells and enhances the ability to analyze hematological dseases.

"The growing cases of blood disorders, technological advancements in hematology analyzers, and rising digital transformation of hematology laboratories globally are the key factors fuelling the global hematology market. Approximately 80 million people alone are affected with blood disorders in the EU."

- Director, Leading Manufacturer of Hematology Analyzers, United States

Competitive Landscape : Hematology Market

The market is marked by the presence of players such Sysmex Corporation, Beckman Coulter/Danaher Corporation, Siemens Healthineers, Abbott, Mindray, Nihon Kohden, Boule Diagnostics, Bio-Rad Laboratories, Horiba, Drew Scientific., among others.

The outlook for the hematology market looks very optimistic due to technological advancements in hematology analyzers, increasing demand for laboratory automation to improve precision and efficiency, growing cases of blood disorders, and adoption of organic and inorganic growth strategies by market players.

Get Detailed Insights on the Hematology Market @

Ruta Halde
Source: » Follow
Posted By:*** Email Verified
Tags:Global Hematology Market
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-tech Insights PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share